| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |